MRVI Maravai LifeSciences Holdings, Inc.: Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Logo perusahaan publik Maravai LifeSciences (MRVI)

The Maravai LifeSciences (MRVI) B2B ecosystem retains clients through strict FDA compliance. Growth is based on the unique CleanCap technology for mRNA synthesis, while reliability is guaranteed by streamlined cold-chain logistics for reagents. The projected earnings per share growth benchmark visualizes market expectations, where -6.30 shows the current value of the metric, confirming the business's financial stability within the medical diagnostics sector.

MRVI: Prakiraan wutah bathi kanggo taun ngarep Maravai LifeSciences Corp 04.07.2022 - 17.11.2026

Rincian analitis lan laporan data perusahaan Maravai LifeSciences Corp (MRVI)

- rega lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:Maravai, MRVI
Produk dadi Maravai LifeSciences Holdings

To assess the credit quality of Maravai LifeSciences (MRVI), the analyst utilizes an EPS growth forecasting model for the coming year, which consolidates daily market expectations for profit dynamics to identify capital drawdown risks. The stability of this metric is supported by the company's exceptional pricing power in the mRNA components segment and its ownership of the CleanCap technology, which creates inelastic demand from the biotechnology sector.

Pesaing utama

A (agilent.com) - Prakiraan wutah bathi kanggo taun ngarep|DGX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|EXAS - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Anbio Biotechnology - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep soterahealth.com|QDEL: Prakiraan wutah bathi kanggo taun ngarep|OPKO Health - Dinamika bathi saben saham sing diarepake ing taun ngarep|CDNA (CareDx, Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Fulgent FLGT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Standard BioTools Inc. (LAB)|CTKB (Cytek Biosciences, Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OSUR (OraSure Corp)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Exagen Inc. (XGN)|MDXH: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Lucid Diagnostics Inc LUCD|PRE (Prenetics Global Ltd) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Insight Molecular|TRIB (Trinity Biotech) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PRPH|Prakiraan wutah bathi kanggo taun ngarep AIMD|Proyeksi tambahing bathi saben saham ing taun ngarep CODX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Heart Test Laboratories HSCS|BMRA: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|CDIO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Onconetix Corp (ONCO) - Prakiraan wutah bathi saben saham kanggo taun ngarep|VRAX (Virax Biolabs Group Ltd) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|AXDX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep centogene.com (CNTG)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Enzo Biochem|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep FRES|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep GTG Labs|23andMe Holding Co - Prakiraan wutah bathi kanggo taun ngarep|PMD - Prakiraan wutah bathi kanggo taun ngarep